OpenVSafe by OpenVAERS
Search V-safe

WXC-30842-06874

3 vaccinations 2 coded responses 13 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
652 / MO
Registered
2020-12-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-20
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-24
    Registered in v-safe
  3. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-10
    Dose 2 — Pfizer-BioNTech
  8. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Musculoskeletal stiffness — Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Neck stiffness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-01-17
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  11. 2021-04-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  12. 2022-01-10
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in
  13. 2022-03-25
    Dose 3 — Pfizer-BioNTech
  14. 2022-04-20
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-04-22
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-05-01
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-05-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-06-24
    Survey response — 3 months, dose 3
    MedDRA: Cough, Headache, Nasal congestion, Pyrexia — Feeling: Fair
    Free text: Headache, cough, stuffy nose, brief fever
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-20Pfizer-BioNTech
22021-01-10Pfizer-BioNTech
32022-03-25Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-12 priority 2/3

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-12

Systemic reaction (other): Neck stiffness

Release 12 — 3 months, dose 3

2022-06-24

Symptoms: Headache, cough, stuffy nose, brief fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDHeadache · · ✓
SDNasal congestion · · ✓
SDPyrexia · · ✓
SROMusculoskeletal stiffness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release